News & updates • Breast Cancer Foundation NZ

News & updates

Our latest news, press releases, blog posts, Pink Ribbon Bulletins & Pink Ribbon Press.

Press release
$300K to target new areas of breast cancer research
11 November 2015

$300K to target new areas of breast cancer research

The NZ Breast Cancer Foundation is calling for proposals to address some of the most challenging areas in breast cancer research, including prevention of the disease, prevention of metastasis (the spread of cancer, which is what causes the 600-plus breast cancer deaths in NZ each year), and improving clinical practice for better patient outcomes.
News
New NZ research focuses on Vitamin C and breast cancer
29 September 2015

New NZ research focuses on Vitamin C and breast cancer

A new research study will analyse the level of vitamin C in breast tumours, and compare health outcomes for patients with different levels of the vitamin.
News
Thumbs-down NZ on International Clinical Trials Day
19 May 2015

Thumbs-down NZ on International Clinical Trials Day

Kiwis have nothing to celebrate this International Clinical Trials Day (tomorrow, Wednesday May 20), says the New Zealand Breast Cancer Foundation.
News
Laser treatment study a first for NZ
06 March 2015

Laser treatment study a first for NZ

International Lymphoedema Awareness Day - March 6, 2015
Press release
BCFNZ marks World Cancer Day with grants to improve knowledge and treatment of local cancers
04 February 2015

BCFNZ marks World Cancer Day with grants to improve knowledge and treatment of local cancers

Today, World Cancer Day, Breast Cancer Foundation NZ announced the winners of its research funding contest for studies based on New Zealand’s breast cancer patient registers, awarding six grants for pilot studies to researchers from Auckland, Waikato, Christchurch and Dunedin.
News
Promising new advanced TNBC drug accessible for NZ women – at a cost
29 January 2015

Promising new advanced TNBC drug accessible for NZ women – at a cost

Results of a small but interesting trial of pembrolizumab (Keytruda) for advanced triple negative breast cancer (TNBC) were released in the USA recently.
Press release
Are we falling behind Australia in terms of access to new cancer drugs? Our reply to PHARMAC's report
26 April 2025

Are we falling behind Australia in terms of access to new cancer drugs? Our reply to PHARMAC's report

In early November PHARMAC published a report investigating whether the differences in the funding of cancer treatments in NZ and Australia impact the health of NZ patients. Below is our response to their report. To read PHARMAC's full report, visit their website.